FR2348927A1 - Nouvelles pyrazolo(4,3-e)(1,2,4-triazolo)(4,3-c)pyrimidines et un procede de leur preparation - Google Patents

Nouvelles pyrazolo(4,3-e)(1,2,4-triazolo)(4,3-c)pyrimidines et un procede de leur preparation

Info

Publication number
FR2348927A1
FR2348927A1 FR7712071A FR7712071A FR2348927A1 FR 2348927 A1 FR2348927 A1 FR 2348927A1 FR 7712071 A FR7712071 A FR 7712071A FR 7712071 A FR7712071 A FR 7712071A FR 2348927 A1 FR2348927 A1 FR 2348927A1
Authority
FR
France
Prior art keywords
triazolo
pyrimidines
preparation
new pyrazolo
pyrazolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7712071A
Other languages
English (en)
French (fr)
Other versions
FR2348927B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2348927A1 publication Critical patent/FR2348927A1/fr
Application granted granted Critical
Publication of FR2348927B1 publication Critical patent/FR2348927B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7712071A 1976-04-21 1977-04-21 Nouvelles pyrazolo(4,3-e)(1,2,4-triazolo)(4,3-c)pyrimidines et un procede de leur preparation Granted FR2348927A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/678,832 US4053474A (en) 1976-04-21 1976-04-21 Pyrazolo[4,3-e][1,2,4]triazolo[4,3-c]pyrimidine

Publications (2)

Publication Number Publication Date
FR2348927A1 true FR2348927A1 (fr) 1977-11-18
FR2348927B1 FR2348927B1 (enExample) 1979-03-09

Family

ID=24724466

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7712071A Granted FR2348927A1 (fr) 1976-04-21 1977-04-21 Nouvelles pyrazolo(4,3-e)(1,2,4-triazolo)(4,3-c)pyrimidines et un procede de leur preparation

Country Status (6)

Country Link
US (3) US4053474A (enExample)
JP (1) JPS52128398A (enExample)
CA (1) CA1082700A (enExample)
DE (1) DE2717549A1 (enExample)
FR (1) FR2348927A1 (enExample)
GB (1) GB1573633A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2402658A1 (fr) * 1977-09-13 1979-04-06 Squibb & Sons Inc Derives didehydrogenes meso-ioniques de 1,7-dihydro-3h-pyrazolo(4,3-e)-1,2,4-triazolo(4,3-c)pyrimidine-3-thiones ou 3-ones 1-substituees, et leur utilisation therapeutique
WO2011012540A1 (en) * 2009-07-27 2011-02-03 F. Hoffmann-La Roche Ag Tricyclic inhibitors of jak

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404380A (en) * 1977-02-14 1983-09-13 Mead Johnson & Company Triazolopyrimidines
US4713383A (en) * 1984-10-01 1987-12-15 Ciba-Geigy Corporation Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses
US4831013A (en) * 1986-03-20 1989-05-16 Ciba-Geigy Corporation 2-substituted-e-fused-[1,2,4]triazolo[1,5-c]pyrimidines, pharmaceutical compositions, and uses thereof
US5047416A (en) * 1989-07-31 1991-09-10 Merck & Co., Inc. Triazole compounds and their use as transglutaminase inhibitors
JP2001508049A (ja) * 1996-12-18 2001-06-19 イーライ・リリー・アンド・カンパニー 縮合ピリミジンライブラリーの組合せ的製造法
MX2010013557A (es) * 2008-06-10 2011-03-24 Abbott Laboratories Star Nuevos compuestos triciclicos.
MX346959B (es) 2009-12-01 2017-04-06 Abbvie Inc Nuevos compuestos triciclicos.
US8785639B2 (en) 2009-12-01 2014-07-22 Abbvie Inc. Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereof
US11512092B2 (en) 2015-10-16 2022-11-29 Abbvie Inc. Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
JP6770775B2 (ja) 2015-10-16 2020-10-21 アッヴィ・インコーポレイテッド (3S,4R)−3−エチル−4−(3H−イミダゾ[1,2−a]ピロロ[2,3−e]−ピラジン−8−イル)−N−(2,2,2−トリフルオロエチル)ピロリジン−1−カルボキサミドおよびそれの固体型の製造方法
US11524964B2 (en) 2015-10-16 2022-12-13 Abbvie Inc. Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
US11365198B2 (en) 2015-10-16 2022-06-21 Abbvie Inc. Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
US11780848B2 (en) 2015-10-16 2023-10-10 Abbvie Inc. Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereof
US10550126B2 (en) 2015-10-16 2020-02-04 Abbvie Inc. Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof
US12365689B2 (en) 2015-10-16 2025-07-22 Abbvie Inc. Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3787430A (en) * 1972-07-13 1974-01-22 Squibb & Sons Inc Derivatives of dipyrazolo(3,4-b;3',4'-d)pyridines
US3850932A (en) * 1973-06-28 1974-11-26 Sandoz Ag 5-(2-carboxy and 2-carboalkoxy-phenylamino)-1,2,4-triazolo-quinazolines
US4020083A (en) * 1975-07-08 1977-04-26 Sandoz, Inc. 5-(2-Aminophenyl)-s-triazoles
US4026893A (en) * 1975-11-07 1977-05-31 Squibb & Sons Inc Pyrazolo{8 1,5-a{9 pyrido{8 3,2-e{9 pyrimidine-7-carboxylic acid derivatives
US7295623B2 (en) * 2001-07-11 2007-11-13 Vativ Technologies, Inc. High-speed communications transceiver

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2402658A1 (fr) * 1977-09-13 1979-04-06 Squibb & Sons Inc Derives didehydrogenes meso-ioniques de 1,7-dihydro-3h-pyrazolo(4,3-e)-1,2,4-triazolo(4,3-c)pyrimidine-3-thiones ou 3-ones 1-substituees, et leur utilisation therapeutique
WO2011012540A1 (en) * 2009-07-27 2011-02-03 F. Hoffmann-La Roche Ag Tricyclic inhibitors of jak

Also Published As

Publication number Publication date
JPS52128398A (en) 1977-10-27
GB1573633A (en) 1980-08-28
US4087423A (en) 1978-05-02
US4053474A (en) 1977-10-11
DE2717549A1 (de) 1977-11-03
US4124764A (en) 1978-11-07
FR2348927B1 (enExample) 1979-03-09
CA1082700A (en) 1980-07-29

Similar Documents

Publication Publication Date Title
FR2348927A1 (fr) Nouvelles pyrazolo(4,3-e)(1,2,4-triazolo)(4,3-c)pyrimidines et un procede de leur preparation
BE856681A (fr) Derives d'acides 5-aroyl-1,2-dihydro-3h-pyrrolo (1,2-a)pyrrole-1-carboxyliques et leur procede de preparation
FR2326924A1 (fr) Pyrido(2,1-b)quinazolin-ones et leur procede de preparation
FR2334357A1 (fr) Nouvelles imidazo (1,2-a) pyridines substituees et leur procede de preparation
IL60330A (en) 7-heteroaryl pyrazolo(1,5-a)pyrimidines
LU80576A1 (fr) Procede de preparation de nouvelles indolo(2,3-a)quinolizidines
BE856732A (fr) Nouvelles thieno (2,3-c) et (3,2-c)pyridines, leur procede de preparation et leurs applications
LU78816A1 (fr) Procede de preparation de tetrahydro-4,5,6,7 thieno(2,3-c)et(3,2-c)pyridines
BE826928A (fr) Pyrrolo (3,4-d) pyrimidines et leur procede de preparation
FR2327785A1 (fr) 1,2,4-triazolo(4,3-b)pyridazin-3-ones
PT67831A (fr) Procede de preparation de thieno(2,3-c)et(3,2-c)pyridines
BE883150A (fr) Pyrido (1,2-a) pyrimidines substituees a action anti-allergique et procede de preparation
AU508926B2 (en) Purines and pyrazolo ( 3, 4-d) pyrimidines
BE863759A (fr) Nouvelles imidazo (1,5-b) pyridazines et procede pour leur preparation
EG12724A (en) Procede de preparation de nouveaux derives benzodiazepines
FR2341581A1 (fr) 2,9-dioxatricyclo(4,3,1,03,7) decanes et procede pour leur preparation
BE868272A (fr) Procede de preparation de thieno (2,3-c) et thieno (3,2-c), pyridines
YU196578A (en) Process for producing 2,3-polymethylene-4-oxo-4h-pyrido(1,2-a)pyrimidine
FR2324301A1 (fr) Nouvelles pyrazolo(3,4-b)pyridyl-5 cetones et procede de leur preparation
BE863570A (fr) 9-(2,5-dihalogenobenzyl)adenines pures, procede pour leur preparation et leur purification
BE856647A (fr) Pyrrolo (3,2-f)quinazoline-1,3-diamines et leur preparation
NZ185302A (en) 2-methyl-6-alkyl-11-(-substituted aminoalkyl)-6,11-dihydro-5h-pyrido (2,3-b) (1,5) benzodiazepin-5-ones
FR2344535A1 (fr) 2-oxo-1-pyrrolidines et leur procede d'obtention
PT69220A (fr) Procede de preparation de thieno(3,2-c) et thieno (2,3-c) pyridines
BE862066A (fr) Agents anti-rhinovirus et procede de leur preparation

Legal Events

Date Code Title Description
ST Notification of lapse